5 Analysts Assess Eton Pharmaceuticals: What You Need To Know
Analysts have set 12-month price targets for Eton Pharmaceuticals, revealing an average target of $24.4, a high estimate of $33.00, and a low estimate of $17.00. Marking an increase of 22.0%, the ...
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
Management to Hold Investor Day Conference Call Today at 10:00am ETReported record product revenue of $11.6 million in Q4 2024, an increase of ...
Q1 EPS Estimate for Eton Pharmaceuticals Raised by Analyst
Investment analysts at B. Riley increased their Q1 2025 earnings estimates for shares of Eton Pharmaceuticals in a research ...
ETF Daily News1d
Eton Pharmaceuticals’ (ETON) “Buy” Rating Reiterated at B. Riley
The firm’s 50-day moving average price is $15.58 and its 200-day moving average price is $11.54. Eton Pharmaceuticals has a 52-week low of $3.03 and a 52-week high of $18.41. The company has a ...
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit New Drug ...
Nasdaq4d
5 Analysts Assess Eton Pharmaceuticals: What You Need To Know
Eton Pharmaceuticals Inc is a United States based ... This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details. Mar 2021 HC Wainwright & Co ...